The meta-chlorophenylpiperazine challenge test in cocaine addicts: Hormonal and psychological responses

Biological Psychiatry

Volumn 41, Issue 11, 1997, Pages 1071-1086

  Buydens Branchey, Laure ^a,b   Branchey, Marc ^a   Fergeson, Paul ^a   Hudson, Jeffrey ^a   McKernin, Craig ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

aggression; Cocaine addicts subtypes; m CPP; serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; COCAINE; HYDROCORTISONE; PROLACTIN;

ADULT; AGGRESSION; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FAMILY HISTORY; HORMONE RESPONSE; HUMAN; MALE; PERSONALITY DISORDER; PRIORITY JOURNAL; PROVOCATION TEST; PSYCHOLOGICAL ASPECT; SEROTONINERGIC SYSTEM;

ADULT; ANXIETY; COCAINE; HUMANS; HYDROCORTISONE; MALE; PIPERAZINES; PROLACTIN; SEROTONIN AGONISTS; SUBSTANCE-RELATED DISORDERS;

EID: 0030960725     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00182-5     Document Type: Article

References (51)

1. Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH (1994): Neuroendocrine and behavioral responses to intravenous m-CPP in depressed patients and healthy comparison subjects. Am J Psychiatry 151:1616-1630.
2. Andreasen N, Endicott J, Spitzer R, Winokur G (1977): The family history method using diagnostic criteria. Arch Gen Psychiatry 34:1229-1235.
3. Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989): Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664-2669.
4. Barratt ES (1957): Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep 21:343-349.
5. Benkelfat C, Murphy DL, Hill JI, George DT, Nutt D, Linnoila M (1991): Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48:383.
6. Black EW, Lakoski JM (1990): In vitro electrophysiology of dorsal raphe serotonergic neurons in subchronic cocaine-treated rats: Development of tolerance to acute cocaine administration. Mol Cell Neurosci 1:84-91.
7. Brown GL, Ballenger JC, Minichiello MD, Goodwin FK (1981): Human aggression and its relationship to CSF 5-HIAA, MHPG, and HVA. In Sandler M (ed), Psychopharmacology of Aggression. New York: Raven Press, pp 131-147.
8. Buss AH, Durkee A (1957): An inventory for assessing different kinds of hostility. J Consult Clin Psychol 21:343-349.
9. Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C (1993): Euphorogenic properties of the serotonin partial agonist m-chlorophenylpiperazine in cocaine addicts [letter]. Arch Gen Psychiatry 50:1001.
10. Buydens-Branchey L, Branchey MH, Noumair D (1989): Age of alcoholism onset: I. Relationship to psychopathology. Arch Gen Psychiatry 46:225-230.
11. 2C receptors in mediating the discriminative stimulus properties of m-CPP. Eur J Pharmacol 257:27-38.
12. Charney DS, Woods SW, Goodman WK, Heninger GR (1987): Serotonin function in anxiety. II. Effects of the serotonin agonist m-CPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl) 92:14-24.
13. Cunningham KA, Callahan PM (1991): Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology (Berl) 104:177-180.
14. Cunningham KA, Paris JM, Goeders NE (1992): Serotonin neurotransmission in cocaine sensitization. Ann NY Acad Sci 654:117-127.
15. Dakis CA, Gold MS (1985): New concepts in cocaine addiction: The dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469-477.
16. Dunwiddie TV (1988): Mechanisms of cocaine abuse and toxicity: An overview. NIDA Res Monogr 88:337-353.
17. Errico AL, Parsons OA, King AC, Lovallo WR (1993): Attenuated response to biobehavioral Stressors in sober alcoholics. J Stud Alcohol 54:393-398.
18. Fishbein DH, Dax E, Lozovsky DB, Jaffe JH (1992): Neuroendocrine responses to a glucose challenge in substance users with high and low levels of aggression, impulsivity and antisocial personality. Neuropsychobiology 25:106-114.
19. Freedman DX (1986): Hallucinogenic drug research - If so, so what? Symposium, summary and commentary. Pharmacol Biochem Behav 24:407-415.
20. Fuller RW (1981): Serotonergic stimulation of pituitary-adrenocortical function in rats. Neuroendocrinology 32:118-127.
21. Fuller RW, Snoddy HD (1980): Effect of serotonin-releasing drugs on serum corticosterone concentration in rats. Neuroendocrinology 31:96-100.
22. Garcia-Borreguero D, Jacobsen FM, Murphy DL, Joseph-Vanderpool JR, Chiara A, Rosenthal NE (1995): Hormonal responses to the administration of m-CPP in patients with seasonal affective disorder and controls. Biol Psychiatry 37:740-749.
23. Gawin FH, Kleber HD (1985): Neuroendocrine findings in chronic cocaine abusers: A preliminary report. Br J Psychiatry 147:569-573.
24. Gibbs DM, Vale W (1983): Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophyseal portal blood. Brain Res 280:176-179.
25. Gold MS, Washton AM, Dackis DA (1985): Cocaine abuse: Neurochemistry, phenomenology and treatment. NIDA Res Monogr 61:130-150.
26. Hamik A, Peroutka SJ (1989): 1-(m-Chlorophenyl) piperazine (m-CPP) interaction with neurotransmitter receptors in the human brain. Biol Psychiatry 25:569-575.
27. Hollander E, DeCaria CM, Nitescu A, et al (1992): Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49:21-28.
28. Hollander E, Stein DJ, DeCaria CM, et al (1994): Serotonin sensitivity in borderline personality disorder: Preliminary findings. Am J Psychiatry 151:277-280.
29. Invernizzi R, Cottechia A, De Blasi T, Mennini R, Samanin R (1981): Effects of m-CPP on receptor binding and brain metabolism of monoamines in rats. Neurochem Int 3:239-244.
30. Jacobs BL (1987): How hallucinogenic drugs work. Am Scientist 75:386-392.
31. Jacobsen FM, Mueller EA, Rosenthal NE, Rogers S, Hill JL, Murphy DL (1993): Behavioral responses to intravenous m-CPP in patients with seasonal affective disorder and control subjects before and after phototherapy. Psychiatry Res 52:181-197.
32. Kahn RS, Wetzler S (1991): M-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139-1166.
33. Kahn RS, Knott P, Gabriel S, Dumont K, Mastroianni L, Davidson M (1992): Effect of m-CPP on plasma homovanillic acid in healthy subjects. Biol Psychiatry 32:1055-1061.
34. Krystal JH, Webb E, Cooney E, Kranzler HR, Charney DS (1994): Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms. Arch Gen Psychiatry 51:898-911.
35. Lee MA, Meltzer HY (1994): Blunted oral body temperature to MK-212 in cocaine addicts. Drug Alcohol Depend 35:217-222.
36. Linnoila M, Virkunnen M, Sheinin M, Rimon R, Goodwin FK (1983): Low cerebro-spinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non impulsive violent behavior. Life Sci 33:2609-2614.
37. Mendelson JH, Teoh SK, Lange U, et al (1988): Anterior pituitary, adrenal and gonadal hormones during cocaine withdrawal. Am J Psychiatry 145:1094-1098.
38. Moss HB, Yao JK, Panzak GL (1990): Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 28:325-338.
39. Murphy DL, Mueller EA, Hill JL, Tolliver TJ, Jacobsen FM (1989): Comparative anxiogenic, neuroendocrine and other physiologic effects of m-CPP given intravenously or orally to healthy volunteers. Psychopharmacology (Berl) 98:275-282.
40. 1C receptor activation by hallucinogenic drugs. Psychopharmacology (Berl) 105:340.
41. Satel SL, Price LH, Palumbo JM, et al (1991): Clinical phenomenology and neurobiology of cocaine abstinence: A prospective inpatient study. Am J Psychiatry 148:1712-1716.
42. Schuckit MA, Gold E, Risch C (1987): Plasma cortisol levels following ethanol in sons of alcoholics and controls. Arch Gen Psychiatry 44:942-945.
43. Schuckit MA, Risch SC, Gold EO (1988): Alcohol consumption, ACTH level and family history of alcoholism. Am J Psychiatry 145:1391-1395.
44. Silverstone PH, Rue JE, Franklin M et al (1994): The effects of administration of m-CPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers. Int Clin Psychopharmacol 9:173-178.
45. Spitzer RL, Williams JB, Gibbon M, First MB (1990): User's Guide for the Structured Clinical Interview of the DSM III R. Washington, DC: American Psychiatric Press.
46. Suckow RF, Cooper TB, Kahn RS (1990): High-performance liquid Chromatographic method for the analysis of plasma m-chlorophenylpiperazine. J Chromatogr A 528:228-234.
47. Tuomisto J, Mannisto P (1985): Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37:249-332.
48. Van de Kar LD, Karteszi M, Bethea CL, Ganoong WF (1985): Serotonergic stimulation of prolactin and corticosterone is mediated by different pathways from the mediobasal hypothalamus. Neuroendocrinology 41:380-384.
49. Virkkunen M, Linnoila M (1990): Serotonin in early onset male alcoholics with violent behavior. Ann Med 22:327-331.
50. Waltman C, McCaul ME, Wand GS (1994): Adrenocorticotropin responses following administration of ethanol and ovine corticotropin-releasing hormone in the sons of alcoholics and control subjects. Alcohol Clin Exp Res 18:826-830.
51. Wilkins JN, Gorelick DA, Nademanee K, Taylor A, Herzberg DS (1992): Hypothalamo-pituitary function during alcohol exposure and withdrawal and cocaine exposure. In Galanter M (ed), Recent Development in Alcoholism, vol 10. New York: Plenum, pp 57-71.